The cellular itinerary and processing of insulin and proinsulin were studied to elucidate possible mechanisms for the observed in vivo differences in the biologic half-lives of these two hormones. A rat fibroblast cell line transfected with a normal human insulin receptor gene was used. 
Introduction
With the successful production of large quantities of human proinsulin (HPro)' by means of recombinant DNA techniques (1, 2) , interest has been growing in the comparison of the kinetics and physiologic effects of proinsulin and insulin. In vivo studies of HPro action have established that the prohormone differs significantly from insulin. Proinsulin's effects, which consist of increasing glucose disposal rate and suppressing hepatic glucose output, develop more slowly than insulin's effects (3) (4) (5) (6) (7) (8) . Furthermore, the duration of the biological effects in vivo of HPro is markedly prolonged relative to those of insulin, which is only partially explained by the differences in the circulating half-lives ofinsulin and HPro (6) (7) (8) . These findings suggest that some process distal to serum HPro levels contribute to the markedly prolonged biologic half-life of this hormone.
In vitro studies to date have not elucidated the possible mechanisms underlying the observed in vivo differences in the kinetics of insulin and proinsulin action. Using isolated rat adipocytes or cultured rat hepatocytes, no differences have been found between insulin and proinsulin in the activation or deactivation of glucose transport (9-11), nor in glucose incorporation into lipid (10) . Thus, it is unlikely that a delayed or prolonged "postreceptor" or intracellular action of proinsulin is responsible for the observed in vivo differences between the two hormones. Therefore, it seemed possible that differences in cellular processing of the two hormones might exist. After binding of insulin to the receptor, the hormone enters the cell via receptor-mediated endocytotic uptake. After internalization, most of the insulin is degraded; however, a significant proportion is released intact (12) (13) (14) . This pathway has been referred to as transcytosis in endothelial cells (14) and retroendocytosis (12, 13) in peripheral target tissues, and may be important in preserving the biologic signal for insulin action (12) .
Due to the markedly reduced binding affinity of proinsulin, studies of proinsulin cellular processing have proven difficult, and relatively little information exists. Binding and internalization studies conducted in the past have relied on the use of large amounts of target tissue, which presents conditions that lead to significant extracellular hormone degradation and compromise cell viability. Furthermore, results have varied greatly, which may be largely due to the relatively high proportion of nonspecific to specific binding (9-11, 15, 16) . To overcome some ofthese problems, we have studied insulin and proinsulin binding and processing in rat fibroblasts that have been transfected with the normal human insulin receptor (HIRC) gene. Due to gene amplification these cells express large numbers of receptors (-1.2 X 106/cell) and, therefore, provide an ideal model to study cellular processing ofHPro. In these cells receptors internalize, recycle, and mediate insulin degradation in a normal manner (17) . The current studies show that HIRC cells bind and internalize HPro with a slower time course. Additionally, HPro is degraded less efficiently via a chloroquine-sensitive pathway, and a greater proportion of internalized HPro enters the nondegradative, retroendocytotic pathway.
Methods
Cell culture. Stable lines of Rat I fibroblasts transfected with a plasmid containing the HIRC gene as well as the gene for dihydrofolate reductase were prepared as previously described (17, 18) . Cells were grown in T75 flasks (Costar, Data Packaging Corp., Cambridge, MA) in DME with 10% FCS and 500 nM methotrexate. 2-3 d before an experiment, 60-mm culture dishes (Costar) were seeded with 0.5-5 X I0O cells/dish with the above media.
Measurements ofinsulin binding and internalization. The radiolabeled ligands used in these experiments consisted of monoiodinated insulin and proinsulin with the '25I incorporated into the tyrosine that corresponds to position 14 ofthe insulin A chain for both ligands (15) . After washing three times with 2 ml of binding buffer (MEM, 25 mM Hepes, 25 mM tricine, 1% BSA), monoiodinated 125I-A'4-insulin (porcine) or monoiodinated human '25I-A14-proinsulin (15), in addition to varying concentrations ofcold pork insulin or human proinsulin, were added to a final volume of 2 ml of binding buffer at pH 7.6, 4-370C. Unless otherwise indicated, the concentrations of radiolabeled insulin and proinsulin were 0.1 and 1.0 nM, respectively. After the desired incubation period, the cells were washed five times with 2 ml of PBS, pH 7.4 at 4VC. I ml of0.1 N NaOH was added to each dish, which was then shaken for 30 min at 37°C to solubilize the cells and release them from the dish. After the dishes were washed with an additional 1 ml of 0.1 N NaOH, the total cell-associated radioactivity was quantitated by counting the solubilized cell solution and the wash in a counter (model 4000; Beckman Instruments, Inc., Fullerton, CA). The specific cell-associated radioactivity was calculated by subtracting the cell-associated radioactivity found in cells that were incubated in the presence of 2 gg/ml of either cold insulin or proinsulin (nonspecific cell-associated radioactivity) from the total cell-associated radioactivity found at tracer ligand concentrations.
Cell-associated radioactivity represents both ligand bound to the plasma membrane receptor and internalized radioactivity. Internalized cell-associated radioactivity was determined based on the principle that surface receptor-bound ligand can be removed by exposing cells to a low pH at low temperatures as was first reported by Haigler (19) . Using this method, the non-acid-extractable radioactivity represents internalized radioactivity. After the cells were preincubated at 37°C for the indicated time periods, they were rapidly cooled to 4°C by being washed five times with 2 ml of PBS at 40C. All intracellular processing, and release of intracellular radioactivity, is inhibited at this temperature (12) . 2 ml of binding buffer, titrated to pH 3.5, was added to the dishes and vigorously shaken at 4°C for 10 min. The cells were washed three more times with 2 ml of 40C, acidic binding buffer, and three times with 2 ml of PBS, 40C . Control experiments to determine the efficiency of the removal of surface receptor-bound insulin revealed that when cells were incubated with '25I-insulin or proinsulin for 90 min at 40C (a temperature where internalization is completely inhibited), > 99% of the cell-associated radioactivity was extracted (data not shown).
The protein content of each dish was determined by using the protocol of Lowry et al. (20) .
Release of internalized cell-associated material. After cells were incubated for 20 or 120 min at 370C with monoiodinated insulin and proinsulin, respectively, the cells were cooled, and after acid was extracted as described above, they were washed five times with PBS to remove all extracellular radioactivity. After aspirating the final wash, 2 ml of 37°C binding buffer was added and the cells were reincubated at 37°C. At the indicated times, 1 ml of buffer was removed and the radioactivity was analyzed either by Sephadex G-50 gel chromatography or by its ability to precipitate in 7.5% TCA. The cell-associated radioactivity was measured as described above or solubilized in 1 ml of 1% Triton X-100, 4 M urea, 1 M acetic acid, and applied to a Sephadex G-50 column.
Chromatography. Sephadex G-50 chromatography was performed using a 0.9 X 50 cm column previously standardized with '25I-A'4-insulin or iodinated human proinsulin. 1 ml of radioactive material was layered onto the column and eluted with 1 M acetic acid, 0.1% BSA, and 1-ml fractions were collected as previously described ( 12) . Recovery was > 95% of the total counts applied. Samples prepared for reverse phase HPLC were applied to Sephadex columns and eluted with only 1 M acetic acid. The columns, however, were previously exposed to BSA.
Reverse phase HPLC was performed using a modified protocol of Frank et al. (21) . Radioactive samples, dissolved in 0.1 N HCl, were applied using a l-ml sample loop to a C-18 analytic column (C-18; Bondapak, Waters Associates, Milford, MA). The column eluant was derived from solvents A and B using a 30-min linear gradient from 25% acetonitrile to 35% acetonitrile in 0.3 M (NH4)2SO4, pH 6.0, 22-C.
Results
Binding competition studies were performed by incubating the HIRC cells with either '25I-proinsulin or '25I-insulin and various concentrations of unlabeled HPro or insulin for 18 h at 4VC. Fig. 1 , A and B demonstrate that unlabeled HPro competes poorly for both labeled ligands. 50% inhibition of tracer insulin or proinsulin binding occurred at insulin and proinsulin concentrations of 0.85-0.95 nM and 140-150 nM, respectively, which indicates that proinsulin has an apparent binding potency of < 1% for insulin. These results are consistent with previous reports and demonstrate that the expressed human Another way to examine internalization of ligand is to measure the effect of chloroquine on cell-associated radioactivity. Chloroquine, a lysosomotropic agent, has been shown to inhibit intracellular degradation of insulin, leading to accumulation of insulin within the cell (23) . As seen in Fig. 3 , A and B, incubating HIRC cells with 100 uM chloroquine results in a similar 140% increase in cell-associated radioactivity in cells that were incubated with insulin and proinsulin at 20 and 120 min, respectively. Cell-associated radioactivity does not plateau in the presence of chloroquine in the time periods measured. The effect of chloroquine on ligand degradation by HIRC cells was assessed by measuring the rate of appearance in the media of extracellular radioactivity that was soluble in 7.5% TCA. The inhibitory effect of chloroquine on ligand degradation was more pronounced in cells incubated with insulin than with proinsulin. As seen in Fig. 3 C, Fig. 4 A. Radioactivity in cells that were preincubated with insulin declined more than in those that were preincubated with proinsulin; 50% of the cellassociated radioactivity was released in 7 vs. 10 min, respectively (P < 0.05). By 30 min, 92% ofthe radioactivity had been released from cells preincubated with insulin compared with 80% in cells preincubated with proinsulin.
The appearance of internalized radioactivity in the media and its ability to precipitate in 7.5% TCA is shown in Fig. 4 served over a range of tracer insulin (0.02-0.1 nM) and proinsulin (0.1-1 nM) concentrations, i.e., the proportion of internalized ligand that is degraded or released intact is constant for both hormones and the differences observed in the processing of insulin and proinsulin are the same at all tracer ligand concentrations tested (data not shown). The composition of the intracellular and released radioactivity was assessed using Sephadex G-50 gel chromatography. After incubating the cells with tracer concentrations ofinsulin or proinsulin for 20 or 120 min, the cells were cooled and washed, and the surface-bound ligand was extracted with acid medium. At the indicated times after reincubating the cells in 370C, insulin-free buffer, medium was removed and the cells were solubilized. The medium or solubilized cell solution was then placed on Sephadex G-50 columns. The time course for cell-associated radioactivity in cells preincubated with insulin is shown in Fig. 5 A. Two prominent peaks are demonstrated. The first peak coelutes with intact '251-insulin at fraction 29 and the second peak coelutes with small molecular weight degradation products at fraction 50. Initially, the intracellular radioactivity is composed of 80% material that coelutes with intact insulin and 20% degradation products. 10 min after the fresh medium was added, the cell-associated material declines rapidly due almost entirely to the fall in the intact insulin peak. By 20 min, intact insulin as well as degraded products decline further and constitute 70 and 30% of the total cell-associated radioactivity, respectively. The time course of proinsulin-derived, cell-associated radioactivity is shown in Fig. 5 B . Two peaks are again demonstrated. Intact proinsulin elutes in fraction 24 which is consistent with its molecular weight being greater than insulin's. In contrast to insulin, the percent ofthe intracellular material that is composed of low molecular weight degradation products is very small, and with time, doesn't change appreciably. As with insulin, however, intact material rapidly declines with time.
With both ligands, the decline of the intact peak could be -INSULIN Figure 6 . Sephadex G-50 chromatography profiles of the appearance of radioactivity into the medium. The same experiment described in the legend from Fig. 5 was performed here except that instead of measuring cell-associated radioactivity, the medium was placed on a Sephadex column at the indicated times after reincubation in fresh buffer.
FRACTION NUMBER Figure 5 . Sephadex G-50 chromatography profiles of the dissociation of intracellular radioactivity. HIRC cells were incubated with either 0.1 nM 1251-insulin for 20 min (A) or 1 nM 251I-proinsulin for 120 min (B), then acid extracted to remove surface receptor-bound insulin, washed, and reincubated with fresh insulin-free buffer. At the indicated times after reincubation, the cells were solubilized as described in Methods and applied to Sephadex G-50 columns.
due theoretically to the release of intact ligand from the cell or to the conversion of intact ligand into low molecular weight degradation products which are subsequently released from the cell. To determine the composition ofthe released radioactivity, the medium was analyzed by Sephadex G-50 gel chromatography over time. As shown in Fig. 6 A, both degradation products as well as intact insulin are released in the first 10 min. However, after 10 min, no additional intact insulin is released while degradation products continue to appear in the medium. Integrating Figs. 5 and 6 A, the initial fall in intact insulin is due to both the release ofintact material from the cell as well as to its conversion into degraded products with subsequent release. However, after 10 min, the fall in intracellular intact insulin is due entirely to the conversion of insulin into low molecular weight degradation products and their release.
The appearance of proinsulin-derived radioactivity is shown in Fig. 6 B. In contrast to insulin, a much higher percentage of proinsulin is released intact both 10 and 20 min after the addition of fresh 370C media. Intact proinsulin constitutes 72% of the released radioactivity at min and 51% at 20 min compared with values of 47 and 35% for insulin. In contrast to insulin, a small amount of intact proinsulin is released between 10 and 20 min. However, most of the radioactivity released into the medium from 10 to 20 min is composed of low molecular weight degradation products. Integrating Figs. 5 and 6 B, the decline of cell-associated, intact proinsulin in the first 10 min is mostly due to the release of intact proinsulin. However, between 10 and 20 min, the decline of intact proinsulin is due to the release of proinsulin from the cell as well as to the conversion of proinsulin into degradation products that subsequently appear in the media.
In cells incubated with proinsulin, a peak on Sephadex G-50 that coelutes with intact proinsulin was demonstrated intracellularly as well as in the medium. However, it has been previously shown in various insulin target tissues that material pooled from the intact peak on Sephadex G-50 is actually composed of both intact ligand as well as of intermediates, which can be separated on reverse phase HPLC (24) (25) (26) (32) . In the present study, the fact that chloroquine ogical problems when increased cell-associated radioactivity (see Fig. 3 
column fractions
HPro not only bypasses degradation, but it traverses the remedium (Fig. 6 B. 20 troendocytotic pathway to a much greater extent than insulin. d, lyophilized, and disThus, a larger proportion ofinternalized HPro is released from plied to a C-18 reverse the cell intact compared with insulin.
The present study of in vitro cellular processing may exProinsulin Versus Insulin Cellular Metabolism 1375 plain some of the in vivo differences in the kinetics of insulin and HPro biologic action. Binding of hormone to the insulin receptor initiates signals responsible for biologic actions. One component of the mechanisms underlying deactivation of the biologic response is degradation of the ligand (32) (33) (34) (35) . One may speculate that processes that bypass hormone degradation will most likely iend to preserve or maintain biologic effects, and cells process HPro in ways that can potentially preserve biologic responsiveness. After internalization, a larger fraction of HPro is sorted away from the degradative pathway and into the nondegradative retroendocytotic pathway. Therefore, relative to insulin, HPro can potentially remain associated with the receptor for a longer time and more of it can be released intact from the cell back into the interstitial space. Theoretically, this would maintain a relatively higher and more prolonged hormone concentration at the tissue site of hormone action, which would enable HPro to bind once again to surface receptors and reinitiate a response. Thus, cellular processes such as sorting and retroendocytosis may preserve the actions of HPro and prolong its in vivo biologic half-life.
The precise biochemical mechanisms underlying the reduced rates of degradation and enhanced retroendocytosis of proinsulin compared with those of insulin are not elucidated by the current study. Conceivably, there is a specific sorting signal(s) that targets internalized insulin receptor-bound ligand toward degradative or retroendocytotic pathways. In this event, these intracellular targeting processes might perceive a proinsulin-occupied, internalized receptor differently from a receptor occupied with insulin, leading to differential sorting. Alternatively, there could be ligand-specific differences in the association rates, dissociation rates, and/or the pH and ionic dependency of these binding processes once the ligand receptor complex is internalized. If such differences led to more prolonged, or stable, proinsulin receptor occupancy, compared with that of insulin, then this might protect proinsulin from the normal intracellular degradative processes and allow more of the proinsulin to remain receptor-bound as the receptor recycles back to the plasma membrane, and this would lead to enhanced retroendocytosis. Although we favor the latter possibility, clearly further studies will be necessary before exact biochemical mechanisms can be determined.
